Navegação Technical documents and research evidence on COVID-19 por assunto "Respiratory Distress Syndrome"
Itens para a visualização no momento 1-4 of 4
-
Drugs for treating acute respiratory distress syndrome (ARDS) in critically ill patients
(2020-03-16)What is this? Some patients with COVID-19 will develop acute respiratory distress syndrome (ARDS) and need help with their breathing. ARDS is caused by direct or indirect injury to the lungs and about 40% of people with ... -
High levels of PEEP are not better than low levels for reducing mortality in adult ICU patients with acute respiratory distress syndrome (ARDS) or acute lung injury (ALI)
(2020-03-18)What is this? Some patients with COVID-19 will develop acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) and need help with their breathing. This might be provided by mechanical ventilation (MV) in an ... -
Immunonutrition with omega-3 fatty acids or antioxidants for acute respiratory distress syndrome (ARDS) in adults
(2020-03-17)What is this? Some patients with COVID-19 will develop acute respiratory distress syndrome (ARDS), and may need mechanical ventilation (MV) to help with their breathing. ARDS is an overwhelming systemic inflammatory process ... -
Severe Acute Respiratory Infections Treatment Centre. Practical manual to set up and manage a SARI treatment centre and a SARI screening facility in health care facilities
(2020-03-28)Purpose, scope and audience of this document: This document provides recommendations, technical guidance, standards and minimum requirements for setting up and operating severe acute respiratory infection (SARI) treatment ...